Bifidobacterium lactis Probio-M8 ameliorated the symptoms of type 2 diabetes mellitus mice by changing ileum FXR-CYP7A1

Bifidobacterium lactis Probio-M8 ameliorated the symptoms of type 2 diabetes mellitus mice by changing ileum FXR-CYP7A1

The aim of this study was to investigate the effect of Bifidobacterium lactis Probio-M8 on glucolipid metabolism and gut microbiota (GM) composition in type 2 diabetes mellitus (T2DM) mice. The glucolipid metabolic profiles were analyzed. The 16S rRNA gene sequencing was employed to investigate GM....

Full description

Bibliographic Details
Main Authors:	Chen Ye, Zhao Yaxin, Shen Xin, Zhao Feiyan, Qi Jinxin, Zhong Zhi, Li Dongmei
Format:	Article
Language:	English
Published:	De Gruyter 2022-12-01
Series:	Open Medicine
Subjects:	probio-m8 type 2 diabetes mellitus fxr-cyp7a1 glucolipid metabolism gut microbiota
Online Access:	https://doi.org/10.1515/med-2022-0576

Similar Items

Bifidobacterium animalis subsp. lactis Probio-M8 alleviates abnormal behavior and regulates gut microbiota in a mouse model suffering from autism
by: Zhuangzhuang Miao, et al.
Published: (2024-01-01)

Bifidobacterium lactis Probio‐M8 prevents nonalcoholic fatty liver disease in high‐fat diet‐fed rats: The potential role in modulating gut microbiota
by: Wen Fan, et al.
Published: (2024-03-01)

Bifidobacterium lactis Probio-M8 relieved acute respiratory tract infections in children possibly by modulating the gut microbes and metabolites
by: Yalin Li, et al.
Published: (2024-04-01)

Protective effects of whey protein hydrolysate on Bifidobacterium animalis ssp. lactis Probio-M8 during freeze-drying and storage
by: Haoqian Wang, et al.
Published: (2022-09-01)

Probiotic Bifidobacterium animalis ssp. lactis Probio-M8 improves the properties and organic acid metabolism of fermented goat milk
by: Shuai Guo, et al.
Published: (2022-11-01)

Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes
by: Baoqing Sun, et al.
Published: (2022-04-01)

Innovation characteristics and technology adoption on Probio_FM in the implementation of an integrated farming system in Bangka Tengah
by: Rufti Puji Astuti, et al.
Published: (2022-08-01)

FXR Maintains the Intestinal Barrier and Stemness by Regulating CYP11A1-Mediated Corticosterone Synthesis in Biliary Obstruction Diseases
by: Zequn Li, et al.
Published: (2023-08-01)

THE ECONOMIC EFFICIENCY OF PROBIO_FM TECHNOLOGY: A CASE STUDY OF BALI CATTLE BUSINESS IN CV. DUA AGRIMANDIRI
by: Basri L.T., et al.
Published: (2023-06-01)

Hammerhead-type FXR agonists induce an enhancer RNA Fincor that ameliorates nonalcoholic steatohepatitis in mice
by: Jinjing Chen, et al.
Published: (2024-04-01)

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
by: Insook Kim, et al.
Published: (2007-12-01)

Selection and evaluation of quality markers for the regulation of PXR-CYP3A4/FXR-LXRα by Exocarpium Citri Grandis for the treatment of hyperlipidaemia with dispelling blood stasis and removing phlegm
by: Guangying Wu, et al.
Published: (2024-01-01)

A ludicidade ambiental no jogo probio: dimensões educativas nos portfólios do bioma campos sulinos como potencialidades reflexivas para a educação ambiental
by: Michel Mendes, et al.
Published: (2020-09-01)

<i>Lactobacillus rhamnosus</i> Probio-M9 Improves the Quality of Life in Stressed Adults by Gut Microbiota
by: Yan Zheng, et al.
Published: (2021-10-01)

Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice
by: Mohammad Nazmul Hasan, et al.
Published: (2023-03-01)

Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice
by: Shizhang Wei, et al.
Published: (2023-05-01)

Resveratrol ameliorates triglyceride accumulation through FXR deacetylation in high glucose-treated HepG2 cells
by: Hao Yang, et al.
Published: (2023-08-01)

SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR
by: Shuang Cui, et al.
Published: (2023-02-01)

Comparative Behavioral Phenotypes of Fmr1 KO, Fxr2 Het, and Fmr1 KO/Fxr2 Het Mice
by: Rachel Michelle Saré, et al.
Published: (2019-01-01)

Glycine-β-Muricholic Acid Improves Liver Fibrosis and Gut Barrier Function by Reducing Bile Acid Pool Size and Hydrophobicity in Male <i>Cyp2c70</i> Knockout Mice
by: Mohammad Nazmul Hasan, et al.
Published: (2023-05-01)

MAFB mediates the therapeutic effect of sleeve gastrectomy for obese diabetes mellitus by activation of FXR expression
by: Jian Xu, et al.
Published: (2018-05-01)

Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
by: Jorge C. Correia, et al.
Published: (2015-12-01)

The Inhibition of SARS-CoV-2 and the Modulation of Inflammatory Responses by the Extract of <i>Lactobacillus sakei</i> Probio65
by: Irfan A. Rather, et al.
Published: (2022-12-01)

FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake
by: Ling Li, et al.
Published: (2019-12-01)

Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
by: Sosmitha Girisa, et al.
Published: (2021-07-01)

Structural Investigation for Optimization of Anthranilic Acid Derivatives as Partial FXR Agonists by in Silico Approaches
by: Meimei Chen, et al.
Published: (2016-04-01)

Mapeamento semidetalhado do uso da terra do Bioma Cerrado Semidetailed land use mapping in the Cerrado
by: Edson Eyji Sano, et al.
Published: (2008-01-01)

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice
by: Minghua Yang, et al.
Published: (2023-07-01)

Evidence for the involvement of FXR signaling in ovarian granulosa cell function
by: Kentaro TAKAE, et al.
Published: (2018-11-01)

Activation of FXR pathway does not alter glial cell function
by: Stefanie Albrecht, et al.
Published: (2017-03-01)

Commentary: Can FXR serve as a potential target for COVID-19 prevention?
by: Juan Pang, et al.
Published: (2023-04-01)

Ablation of liver Fxr results in an increased colonic mucus barrier in mice
by: Noortje Ijssennagger, et al.
Published: (2021-10-01)

Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolitesResearch in context
by: Guangqi Gao, et al.
Published: (2023-05-01)

<i>Lacticaseibacillus rhamnosus</i> Probio-M9-Driven Mouse Mammary Tumor-Inhibitory Effect Is Accompanied by Modulation of Host Gut Microbiota, Immunity, and Serum Metabolome
by: Weiqin Zhang, et al.
Published: (2022-12-01)

The Role of the Nuclear Receptor FXR in Arsenic-Induced Glucose Intolerance in Mice
by: Yifei Yang, et al.
Published: (2023-10-01)

Dietary bile acids improve breast muscle growth in chickens through FXR/IGF2 pathway
by: Liang Chen, et al.
Published: (2024-02-01)

Amyloid Properties of the FXR1 Protein Are Conserved in Evolution of Vertebrates
by: Maria E. Velizhanina, et al.
Published: (2022-07-01)

The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
by: Mirza Bojić, et al.
Published: (2019-09-01)

Aspirin Caused Intestinal Damage through FXR and ET-1 Signaling Pathways
by: Qiuxia Lin, et al.
Published: (2024-03-01)

FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection
by: Ju-Hee Kang, et al.
Published: (2021-09-01)